Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum Disorder
Clinical trial NCT03849456 · TERMINATED
Trial details
- NCT number
- NCT03849456
- Sponsor
- Jazz Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-07
- Primary completion
- 2020-05-26
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.